Blepharoplasty Eyelid Lift — Cost, Top Hospitals & Success Rates | MyMedicPlus

Blepharoplasty is a surgical procedure to reshape and rejuvenate the upper and/or lower eyelids by removing or redistributing excess skin, muscle, and fat. As one of the most frequently performed cosmetic surgical procedures worldwide, it addresses both the cosmetic concerns of an aged, tired appearance and the functional issue of visual field obstruction caused by ptotic (drooping) upper eyelid skin.

The upper eyelid accumulates excess skin (dermatochalasis) with age due to loss of skin elasticity and descent of the brow. In severe cases, the overhanging skin impairs the superior visual field, causing functional blepharoplasty — a medically indicated procedure covered by insurance or the NHS when visual field testing demonstrates impairment. The lower eyelid develops under-eye bags (orbital fat herniation through a weakened orbital septum), hollowing (tear trough deformity), and skin laxity, contributing to a fatigued, aged appearance.

Blepharoplasty is performed by oculoplastic surgeons (specialists in eyelid, orbit, and lacrimal surgery) or plastic surgeons with eyelid expertise. Upper blepharoplasty alone is frequently performed under local anaesthesia with or without sedation as a day-case procedure. Combining upper and lower blepharoplasty, or combining blepharoplasty with brow lift or facelift, is typically performed under general anaesthesia. The procedure requires precise anatomical knowledge to avoid damaging critical eyelid structures including the levator aponeurosis (upper lid elevator) and the orbicularis oculi muscle.

Upper eyelid blepharoplasty treats dermatochalasis — excess upper eyelid skin causing a hooded appearance — and its functional consequence, upper visual field obstruction (pseudoptosis from skin draping). True ptosis (drooping of the upper lid margin itself due to levator aponeurosis disinsertion or dehiscence) is corrected by ptosis repair (levator advancement), which is a distinct procedure from or combined with upper blepharoplasty. Festoons and malar bags — collections of lymphedema in the cheek below the lower lid — require specific surgical techniques.

Lower eyelid blepharoplasty addresses orbital fat herniation (under-eye bags), lower lid laxity with or without ectropion (outward turning) or entropion (inward turning), and excess lower lid skin. The procedure can be performed via a transcutaneous approach (external skin incision below the lashes) or a transconjunctival approach (incision inside the lower lid, leaving no external scar), depending on the degree of skin excess and fat repositioning versus simple fat removal required. Asian blepharoplasty (creation of a supratarsal crease in single-eyelid Asian patients) is a distinct variant performed extensively in East Asia and by specialised cosmetic surgeons globally.

Ideal candidates for upper blepharoplasty are individuals over the age of 35 with significant dermatochalasis causing cosmetic concern or visual field restriction, non-smokers, in good general health, without significant dry eye disease, and with realistic expectations. Baseline visual field testing (Goldman or Humphrey perimetry) with lids in natural position and with tape lifting the excess skin is required for functional blepharoplasty claims. Brow position assessment is essential — if brow ptosis (descent of the eyebrow) is the primary cause of apparent upper lid excess, a brow lift rather than blepharoplasty will achieve the correct anatomical correction.

Contraindications include significant dry eye syndrome (reduced tear production or poor Bell's phenomenon — upward eye rotation on closure — increases risk of post-operative exposure keratopathy), thyroid eye disease in the active phase, previous eyelid surgery with altered anatomy, significant coagulation disorders, and use of anticoagulant medications not manageable peri-operatively. Patients with unrealistic expectations regarding outcome, or who are seeking blepharoplasty to address interpersonal or psychological issues, should undergo thorough preoperative counselling.

Upper blepharoplasty involves marking and excising an ellipse of skin (and sometimes a strip of orbicularis muscle) from the upper eyelid crease, with conservatively graded removal of prolapsing medial fat pad if present. The incision is placed in the upper eyelid crease so the resulting scar is concealed in the natural fold. Simultaneous ptosis repair (levator aponeurosis advancement or reinsertion) is performed if true ptosis is present, measured by the margin-reflex distance (MRD1).

Transconjunctival lower blepharoplasty removes or redistributes herniated orbital fat through an internal incision (no skin excision), leaving no visible external scar. This is preferred when skin redundancy is absent or minimal. Transcutaneous lower blepharoplasty (external incision below the lash line) allows skin and muscle excision in addition to fat management, indicated when significant lower lid skin laxity is present. Conservative fat removal versus fat repositioning to fill the tear trough hollowing — placing fat from the herniated bags into the tear trough deficiency — is an important surgical decision affecting aesthetic outcome. Transconjunctival fat repositioning achieves natural, youthful lower lid contour without surface scarring.

Selecting the most appropriate Blepharoplasty Eyelid Lift approach requires a structured assessment of patient-specific factors. The treating specialist evaluates disease severity, prior treatment history, comorbidities, and patient preferences before recommending a specific protocol. Combination approaches are often more effective than monotherapy — integrating pharmacological, procedural, or rehabilitative elements to address multiple disease mechanisms simultaneously. Dose or intensity is titrated incrementally based on clinical response, tolerability, and objective outcome measures. In patients with refractory disease or inadequate response to first-line protocols, escalation to higher-intensity or specialist-delivered treatment options is indicated. Multidisciplinary team (MDT) review ensures that surgical, medical, and allied health perspectives are integrated into the final management plan, particularly for complex or high-risk cases where multiple treatment pathways are viable and the risk-benefit balance requires careful deliberation.

Upper blepharoplasty produces one of the highest patient satisfaction rates of any cosmetic surgery, consistently achieving scores of 85–95% patient satisfaction in published series. The procedure opens the visual field, creates a more youthful and alert appearance, and corrects the tired look caused by skin redundancy. Functional upper blepharoplasty demonstrably improves superior visual field and reduces brow-ache from the constant effort of elevating the brows to compensate for drooping skin.

Lower blepharoplasty eliminates under-eye bags and hollowing, dramatically reducing the appearance of fatigue and ageing. Combined upper and lower blepharoplasty produces comprehensive periorbital rejuvenation that can take 5–10 years off the perceived facial age. Results are long-lasting — typically 5–10 years or longer before the effects of further ageing require consideration of repeat surgery. Functional blepharoplasty also reduces headaches and visual strain caused by the brow-elevating effort required to lift excess eyelid skin.

Blepharoplasty carries specific risks related to eyelid anatomy. The most commonly reported issues are temporary: postoperative bruising and swelling lasting 1–3 weeks; dry eyes from temporary lagophthalmos (incomplete eyelid closure) requiring lubricating drops for 2–6 weeks; and asymmetry in final scar or fold position (minor asymmetry is common and usually self-resolves or is addressable with minor revision).

Serious complications are uncommon but include retrobulbar haemorrhage (bleeding behind the eye) — an ophthalmic emergency occurring in less than 0.05% of cases, presenting with severe pain, proptosis, and visual loss within 24 hours of surgery, requiring immediate lateral canthotomy and cantholysis to decompress the orbit and protect vision. Ectropion (lower lid outward turning) can occur after aggressive lower transcutaneous blepharoplasty, requiring canthopexy or tarsal strip revision. Over-resection of upper lid skin causing lagophthalmos and exposure keratopathy is a serious complication preventable by conservative skin excision — at least 20 mm of skin below the brow must be preserved. Levator injury causing ptosis or asymmetric lid height requires revision surgery.

Cold compresses are applied to the periorbital area for the first 24–48 hours to minimise swelling and bruising. Eyes should be kept moist with lubricating drops (preservative-free) and eye ointment overnight for 2–4 weeks. Patients are advised to sleep with the head elevated on two pillows for 1 week. Most bruising and swelling resolves within 2–3 weeks; residual swelling and scar maturation continues for up to 3–6 months.

Sutures are removed at 5–7 days for upper lid incisions. Driving and reading are restricted for 1 week. Contact lens use is deferred for 2–4 weeks. Strenuous exercise should be avoided for 2–3 weeks. Make-up can be applied after suture removal. Most patients can return to work within 7–14 days, though residual bruising may be concealed with make-up after suture removal. A follow-up appointment at 1 week confirms suture removal and wound assessment; further follow-ups at 3 months and 1 year assess the final aesthetic result.

Blepharoplasty costs vary significantly by the extent of surgery and geographic location. In the United States, upper blepharoplasty alone costs USD 3,000–6,000 in private practice; combined upper and lower blepharoplasty costs USD 5,000–12,000. Functional blepharoplasty with documented visual field impairment may be partially or fully covered by insurance. In the UK, functional blepharoplasty is covered by NHS where visual field criteria are met; cosmetic blepharoplasty private costs range from GBP 2,500–5,000.

Medical tourists seeking cosmetic blepharoplasty find significant cost savings in South Korea (the world's leading cosmetic eyelid surgery destination, particularly for Asian blepharoplasty), Thailand, Turkey, India, and Poland. In Turkey, combined upper and lower blepharoplasty costs USD 1,500–3,000; in Thailand USD 2,000–4,000; in India USD 800–2,500. South Korea offers highly specialised Asian blepharoplasty and revision blepharoplasty at moderate prices with enormous surgical expertise. Accreditation, specific surgeon training in eyelid anatomy (oculoplastic subspecialty), and revision track record are important quality markers beyond cost alone.

Non-surgical alternatives for periorbital ageing include injectable treatments targeting different anatomical changes. Botulinum toxin (Botox, Dysport) relaxes the orbicularis oculi muscle to reduce crow's feet and can subtly elevate the brow tail by reducing the depressor muscle pull — an office-based procedure with no downtime. Dermal fillers (hyaluronic acid — Juvederm Volbella, Restylane) can fill the tear trough hollowing and improve under-eye volume loss, addressing hollowing rather than fat herniation.

Radiofrequency skin tightening (Thermage CPT, Ultherapy) uses energy to stimulate subdermal collagen production, providing mild to moderate skin tightening without surgery — suitable for mild skin laxity in younger patients who are not yet appropriate surgical candidates. Plasma pen (fibroblast) treatment is used in some clinics for mild dermatochalasis but has inconsistent evidence and risk of scarring. All non-surgical approaches have more limited efficacy than surgery for moderate-to-severe dermatochalasis and cannot address significant fat herniation. Surgery remains the most effective and durable intervention for patients with genuine anatomical excess.